Sindy Kim
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Cancer Research top 10%
- Genetics top 10%
- Genetics
- Co-authors
- Dennis J. SlamonEustratios BananisRichard S. FinnNadia HarbeckSeock‐Ah ImHope S. RugoXin HuangDongrui R. Lu
- Topics
- Advanced Breast Cancer Therapies (20 papers)Cancer-related Molecular Pathways (10 papers)HER2/EGFR in Cancer Research (8 papers)
- Partner nations
- United StatesGermanyIreland
In The Last Decade
Sindy Kim
20 papers receiving 647 citations
Hit Papers
Peers
Comparison fields: 5 of 39
- Pulmonary and Respiratory Medicine 575
- Oncology 486
- Cancer Research 274
- Genetics 143
- Genetics 44
Countries citing papers authored by Sindy Kim
This map shows the geographic impact of Sindy Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sindy Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sindy Kim more than expected).
Fields of papers citing papers by Sindy Kim
This network shows the impact of papers produced by Sindy Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sindy Kim. The network helps show where Sindy Kim may publish in the future.
Co-authorship network of co-authors of Sindy Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Sindy Kim. A scholar is included among the top collaborators of Sindy Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sindy Kim. Sindy Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancerbreakdown → | 81 |
| 3 | 4 | |
| 4 | 2 | |
| 5 | Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Studybreakdown → | 114 |
| 6 | 3 | |
| 7 | Overall survival (OS) with first-line palbociclib plus letrozole (PAL+LET) versus placebo plus letrozole (PBO+LET) in women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer (ER+/HER2− ABC): Analyses from PALOMA-2.breakdown → | 109 |
| 8 | 20 | |
| 9 | 7 | |
| 10 | 29 | |
| 11 | 35 | |
| 12 | 111 | |
| 13 | 10 | |
| 14 | 59 | |
| 15 | 53 | |
| 16 | 1 | |
| 17 | 3 | |
| 18 | 6 | |
| 19 | 1 | |
| 20 | 4 |
About Sindy Kim
Sindy Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 20 papers that have together received 653 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (20 papers), Cancer-related Molecular Pathways (10 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Cancer Research (274 citations), Oncology (486 citations) and Pulmonary and Respiratory Medicine (575 citations). Sindy Kim has collaborated with scholars based in United States, Germany and Ireland. Frequent co-authors include Dennis J. Slamon, Eustratios Bananis, Richard S. Finn, Nadia Harbeck, Seock‐Ah Im, Hope S. Rugo, Xin Huang, Dongrui R. Lu, Igor Bondarenko and Janice M. Walshe. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.